Spravato (esketamine) is a prescription nasal spray for certain adults with treatment-resistant depression or major depressive disorder. It is administered under the supervision of a healthcare provider as part of a treatment plan. A qualified provider can determine whether Spravato treatment matches each person’s symptoms, medical history, and treatment goals. Here is more information about navigating the effects of Spravato:
Understanding How Spravato Works
Spravato contains esketamine, which acts on NMDA receptors in the brain. It works differently than many traditional antidepressants and is used with an oral antidepressant for certain adults. A qualified healthcare provider can determine whether Spravato treatment is appropriate based on each person’s diagnosis, medical history, and treatment response.
Attending Spravato Sessions
Each Spravato session follows a structured process in a supervised medical setting. Patients self-administer the nasal spray under the guidance of a qualified healthcare provider. Medical staff remains available throughout the appointment to provide support and monitor the treatment process.
After treatment, patients remain at the office for a monitoring period before leaving. Healthcare providers observe each person’s response and discuss any questions that arise during the visit. Patients receive instructions for transportation and follow-up care before returning home.
Understanding Common Side Effects
Spravato may cause temporary side effects during or after treatment. A healthcare provider reviews possible side effects before treatment and monitors each person throughout the appointment.
Common side effects may include:
- Dizziness
- Dissociation
- Anxiety
- Sleepiness
Patients need transportation home after each treatment session. A healthcare provider gives instructions for post-treatment care and answers questions before the appointment ends. Following these instructions helps patients prepare for treatment days.
Following The Treatment Schedule
Spravato treatment follows a schedule that changes throughout different phases of care. Treatment sessions usually occur more often at the beginning and become less frequent as recommended by the healthcare provider. A qualified provider develops a treatment schedule based on each person’s symptoms, treatment response, and ongoing care plan.
Determining Treatment Eligibility
Spravato is intended for certain adults who meet specific treatment criteria. A qualified mental health provider completes a comprehensive evaluation before recommending treatment. This evaluation reviews symptoms, medical history, and previous depression treatments.
Some people may qualify for Spravato treatment after trying other depression treatments without adequate results. Others are able to qualify based on their diagnosis and clinical needs. A healthcare provider explains eligibility requirements and answers questions during the evaluation process. Treatment recommendations depend on each person’s individual circumstances.
After determining eligibility, the healthcare team develops a treatment schedule and reviews the treatment process. Follow-up appointments help monitor progress and guide future care decisions. Patients should contact a healthcare provider promptly if their symptoms change or worsen during treatment.
Schedule Your Consultation Today
Spravato is a treatment option for certain adults with treatment-resistant depression or major depressive disorder under specific circumstances. A qualified healthcare provider can explain the treatment process, review eligibility requirements, and answer questions during an evaluation. Treatment plans vary based on each person’s symptoms, medical history, and treatment response. Contact a qualified Spravato provider to schedule an evaluation and learn whether this treatment may be appropriate for you.
